InjuryBoard New York City Archives

• New Zealand Study Shows Celebrex Increases Heart Attack Risk Nearly Two-Fold

  Jeremy Thurman | March 03, 2006 5:25 PM | 0 Comments
  Category: Miscellaneous

  People taking the pain reliever Celebrex were at nearly twice the risk for heart attacks as those using rival treatments, according to a study released Wednesday conducted by New Zealand's Medical Research Institute. Celebrex, which is manufactured by Pfizer Inc. and is commonly used to treat arthritis pain, belongs to the class of drugs known as cox-2 inhibitors. Two other drugs in the class,...

• Prescription Painkiller Causes Many Fatalities; Petition Filed Today with FDA

  Jeremy Thurman | March 03, 2006 2:13 PM | 0 Comments
  Category: FDA & Prescription Drugs

  The Public Citizen has petitioned the U.S. Food and Drug Administration (FDA) to immediately begin to phase out the widely prescribed pain reliever propoxyphene (Darvon, Darvocet and generic versions) from the market because the drug has been associated with more than 2,000 accidental deaths, is physically addictive and is no more effective than safer alternatives.

• Bristol-Myers warns diabetics about Tequin

  Jeremy Thurman | March 03, 2006 2:09 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Bristol-Myers Squibb is warning against the use of the antibiotic drug Tequin in diabetic patients after reports of several fatalities per the FDA. The company has also said its adding a contraindication warning for diabetics to the drug's label as well as strengthening its warning that Tequin can cause both low and high blood sugar levels in patients. Bristol-Myers spokesman Eric Miller said...